Article

Risk of Non-Hodgkin Lymphoma Associated with Germline Variation in Genes that Regulate the Cell Cycle, Apoptosis, and Lymphocyte Development

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Rockville, MD 20852, USA.
Cancer Epidemiology Biomarkers & Prevention (Impact Factor: 4.32). 05/2009; 18(4):1259-70. DOI: 10.1158/1055-9965.EPI-08-1037
Source: PubMed

ABSTRACT Chromosomal translocations are the hallmark genetic aberration in non-Hodgkin lymphoma (NHL), with specific translocations often selectively associated with specific NHL subtypes. Because many NHL-associated translocations involve cell cycle, apoptosis, and lymphocyte development regulatory genes, we evaluated NHL risk associated with common genetic variation in 20 candidate genes in these pathways. Genotyping of 203 tag single nucleotide polymorphisms (SNP) was conducted in 1,946 NHL cases and 1,808 controls pooled from 3 independent population-based case-control studies. We used logistic regression to compute odds ratios (OR) and 95% confidence intervals (CI) for NHL and four major NHL subtypes in relation to tag SNP genotypes and haplotypes. We observed the most striking associations for tag SNPs in the proapoptotic gene BCL2L11 (BIM) and BCL7A, which is involved in a rare NHL-associated translocation. Variants in BCL2L11 were strongly related to follicular lymphoma only, particularly rs3789068 (OR(AG), 1.41; 95% CI, 1.10-1.81; OR(GG), 1.65; 95% CI, 1.25-2.19; P(trend) = 0.0004). Variants in BCL7A were strongly related to diffuse large B-cell lymphoma only, particularly rs1880030 (OR(AG), 1.34; 95% CI, 1.08-1.68; OR(AA), 1.60; 95% CI, 1.22-2.08; P(trend) = 0.0004). The associations for both variants were similar in all three studies and supported by haplotype analyses. We also observed notable associations for variants in BCL6, CCND1, and MYC. Our results support the role of common genetic variation in cell cycle, apoptosis, and lymphocyte development regulatory genes in lymphomagenesis, and suggest that effects may vary by NHL subtype. Replication of our findings and further study to identify functional SNPs are warranted.

Download full-text

Full-text

Available from: Sophia Wang, Sep 01, 2015
0 Followers
 · 
137 Views
 · 
61 Downloads
  • Source
    • "P9 , the other gene to be replicated , is a pro - apoptotic protease integral to the intrinsic apoptotic pathway , and is responsible for effector caspase activation and apoptosis execution following activation by Apaf - 1 bound to cytochrome c released from mitochondria ( Allan and Clarke , 2009 ) . The primers and probes used listed previously ( Morton et al . , 2009 ) . For controls , β2 - microglobulin was used in all cases . Each assay was analyzed by the comparative cycle threshold ( CT ) method . Results All the clinicopathological features of the studied samples were collected from pathology and medical records of patients . The variation in gene expression across 40 NHL and normal samples usi"
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Chromosomal translocations are genetic aberrations associated with specific non-Hodgkin lymphoma (NHL) subtypes. This study investigated the differential gene expression profile of Egyptian NHL cases based on a microarray approach. Materials and Methods: The study included tissue samples from 40 NHL patients and 20 normal lymph nodes used as controls. Total RNA was extracted and used for cDNA microarray assays. The quantitative real time polymerase chain reaction was used to identify the aberrantly expressed genes in cancer. Results: Significant associations of 8 up-regulated and 4 down-regulated genes with NHL were observed. Aberrant expression of a new group of genes not reported previously was apparent, including down-regulated NAG14 protein, 3 beta hydroxy-delta 5-c27 steroid oxi-reductase, oxi-glutarate dehydrogenase (lipo-amide), immunoglobulin lambda like polypeptide 3, protein kinase x linked, Hmt1, and caveolin 2 Tetra protein. The up-regulated genes were Rb binding protein 5, DKFZP586J1624 protein, protein kinase inhibitor gamma, zinc finger protein 3, choline ethanolamine phospho-transferase CEPT1, protein phosphatase, and histone deacetylase-3. Conclusions: This study revealed that new differentially expressed genes that may be markers for NHL patients and individuals who are at high risk for cancer development.
    Asian Pacific journal of cancer prevention: APJCP 07/2013; 14(7):4393-8. DOI:10.7314/APJCP.2013.14.7.4393 · 2.51 Impact Factor
  • Source
    • "They in [31] also observed that among DLBCLs, LMO2 tended to be expressed in cases assigned by phenotyping to the GCB categories and can therefore be added to the panel of markers that pathologists may use to subcategorize lymphomas. Morton et al. [32] claimed that LMO2 is one of the candidate genes involved in lymphocyte development and is highly expressed in germinal center lymphocytes. Durnick et al. [33] studied the relationship between LMO2 expression and t(14;18)/IGH-BCL2, a specific marker of lymphomas of germinal center origin and has been specifically associated with the GCB subgroup of DLBCL as determined by gene expression profiling but not in the ABC cases. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A bivariate mixture model utilizing information across two species was proposed to solve the fundamental problem of identifying differentially expressed genes in microarray experiments. The model utility was illustrated using a dog and human lymphoma data set prepared by a group of scientists in the College of Veterinary Medicine at North Carolina State University. A small number of genes were identified as being differentially expressed in both species and the human genes in this cluster serve as a good predictor for classifying diffuse large-B-cell lymphoma (DLBCL) patients into two subgroups, the germinal center B-cell-like diffuse large B-cell lymphoma and the activated B-cell-like diffuse large B-cell lymphoma. The number of human genes that were observed to be significantly differentially expressed (21) from the two-species analysis was very small compared to the number of human genes (190) identified with only one-species analysis (human data). The genes may be clinically relevant/important, as this small set achieved low misclassification rates of DLBCL subtypes. Additionally, the two subgroups defined by this cluster of human genes had significantly different survival functions, indicating that the stratification based on gene-expression profiling using the proposed mixture model provided improved insight into the clinical differences between the two cancer subtypes.
    Human genomics 01/2013; 7(1):2. DOI:10.1186/1479-7364-7-2
  • [Show abstract] [Hide abstract]
    ABSTRACT: Current testing has been found to be useful for testing CMOS ICs because it can detect a large class of manufacturing defects. The concept of current testing is described; the classes of defects detectable by current testing and the conditions to detect a given defect are described; and a general test-vector generation algorithm for current testing is developed and applied to two examples
    European Test Conference, 1989., Proceedings of the 1st; 05/1989
Show more